Literature DB >> 27206260

Abductor Muscle Function and Trochanteric Tenderness After Hemiarthroplasty for Femoral Neck Fracture.

Arkan S Sayed-Noor1, Aleksandra Hanas, Olof G Sköldenberg, Sebastian S Mukka.   

Abstract

OBJECTIVES: To compare the abductor muscle function and trochanteric tenderness in patients operated with hemiarthroplasty using the direct lateral (DL) or posterolateral (PL) approach for displaced femoral neck fracture.
DESIGN: Prospective cohort study.
SETTING: A secondary teaching hospital. PARTICIPANTS: We enrolled 183 hips operated with hemiarthroplasty for displaced femoral neck fracture using the DL or PL approach.
INTERVENTIONS: Preoperatively, we evaluated the Harris hip score (HHS) and European Quality of Life-5 Dimensions (EQ-5D). At 1 year postoperatively, lucid patients were clinically examined to evaluate the Trendelenburg sign, abductor muscle strength with a dynamometer, and trochanteric tenderness with an electronic algometer. The 1-year HHS and EQ-5D were documented. MAIN OUTCOME MEASURES: The primary outcome was the incidence of postoperative Trendelenburg sign, whereas the secondary outcomes included patients' reported limp, abductor muscle strength, trochanteric tenderness, HHS, and EQ-5D.
RESULTS: There were 48 patients (24 in the DL group and 24 in the PL group) who attended the 1-year clinical follow-up. The 2 groups were comparable (P > 0.05). The DL group showed a higher incidence of the Trendelenburg sign (9/24 vs. 1/24, P = 0.02) and limp (12/24 vs. 2/24, P = 0.004). Further analysis with logistic regression showed the surgical approach to be the only factor that resulted in the increment. No differences regarding HHS, EQ-5D, abductor muscle strength, algometer pressure pain threshold, and radiologic measurements were found (P > 0.05).
CONCLUSIONS: The incidence of the Trendelenburg sign and limp were significantly higher in the DL approach although this seemed not to influence abductor muscle strength or the incidence of trochanteric tenderness or compromise the clinical outcome. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2016        PMID: 27206260     DOI: 10.1097/BOT.0000000000000532

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  5 in total

1.  The optimal approach in hip hemiarthroplasty: a cohort of 1009 patients.

Authors:  E N de Vries; T J Gardenbroek; H Ammerlaan; F Steenstra; A M J S Vervest; M Hogervorst; R van Velde
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-12-19

2.  Anterolateral minimally invasive hip approach offered faster rehabilitation with lower complication rates compared to the minimally invasive posterior hip approach-a University clinic case control study of 120 cases.

Authors:  Marko Ostojić; David Kordić; Goran Moro; Zdenko Ostojić
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-02       Impact factor: 3.067

3.  Reduced revision rate and maintained function after hip arthroplasty for femoral neck fractures after transition from posterolateral to direct lateral approach.

Authors:  Sebastian Mukka; Björn Knutsson; Ammar Majeed; Arkan S Sayed-Noor
Journal:  Acta Orthop       Date:  2017-08-10       Impact factor: 3.717

4.  Prospective comparison of the anterior and lateral approach in hemiarthroplasty for hip fractures: a study protocol.

Authors:  Max P L van der Sijp; Inger B Schipper; Stefan B Keizer; Pieta Krijnen; Arthur H P Niggebrugge
Journal:  BMC Musculoskelet Disord       Date:  2017-08-23       Impact factor: 2.362

5.  Posterolateral or direct lateral approach for cemented hemiarthroplasty after femoral neck fracture (APOLLO): protocol for a multicenter randomized controlled trial with economic evaluation and natural experiment alongside.

Authors:  Maria C J M Tol; Nienke W Willigenburg; Hanna C Willems; Taco Gosens; Ariena Rasker; Martin J Heetveld; Martijn G M Schotanus; Johanna M Van Dongen; Bart Eggen; Mate Kormos; Stéphanie L Van der Pas; Aad W Van der Vaart; Rudolf W Poolman
Journal:  Acta Orthop       Date:  2022-09-12       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.